The incidence of deep vein thrombosis in Japanese patients undergoing endoscopic submucosal dissection Masafumi Kusunoki, MD, Kazumasa Miyake, MD, PhD,Tomotaka.

Slides:



Advertisements
Similar presentations
DURNER L.,BOURDOUMIS A., MASOOD J., BUCHHOLZ N. ROYAL LONDON HOSPITAL, BARTSHEALTH NHS TRUST ROYAL DEVON AND EXETER NHS TRUST HOMERTON UNIVERSITIY HOSPITAL.
Advertisements

Post oral surgery bleeding for adult patients receiving antithrombotic therapy.
Prophylaxis of Venous Thromboembolism
Deep Vein Thrombosis (DVT)
Consistent Venous Thromboembolism Risk Reduction by Extended- Versus Standard-Duration Enoxaparin Prophylaxis in Subgroups of Acutely Ill Medical Patients.
Below the Knee DVT and Pregnancy Related Thrombosis Robert Lampman, MD Morning Report July 2009.
RACIAL DISPARITIES IN PRESCRIPTION DRUG UTILIZATION AN ANALYSIS OF BETA-BLOCKER AND STATIN USE FOLLOWING HOSPITALIZATION FOR ACUTE MYOCARDIAL INFARCTION.
DVT/VTE Nursing Protocol (Deep Vein Thrombosis) (Venous Thromboembolism) Presented by Maribeth Desiongco MA, RN-BC 2008.
Extended Anticoagulation in VTE Geoffrey Barnes, MD Cardiovascular and Vascular Medicine University of Michigan, USA 1 st Qatar Conference on Safe Anticoagulation.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2012.
Supervisor: Vs 余垣斌 Presenter: CR 周益聖. INTRODUCTION.
Journal Club Increased Rheumatoid Factor and Deep Venous Thrombosis: 2 Cohort Studies of 54,628 Individuals from the General Population C.L. Meyer-Olesen,
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
Peri-operative management of anticoagulation Marc Carrier MD, MSc FRCPC Assistant Professor, University of Ottawa Associate Scientist, Ottawa Health Research.
Systemic Hypertension. Systemic blood pressure measures 140/90 mm Hg or higher on at least two occasions a minimum of 1 to 2 weeks apart.
Evaluating the Performance of a Previously Reported Risk Score to Predict Venous Thromboembolism: A VERITY Registry Study Denise O'Shaughnessy, Peter Rose,
Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer Agnelli G et al. N Engl J Med 2012;366(7): George D et al. Proc.
Blood Pressure Lability During Cardiac Surgery Is Associated With Adverse Outcomes Solomon Aronson, Edwin G. Avery, Cornelius Dyke, Joseph Varon, Jerrold.
Endarterectomy versus Stenting in Patients with Symptomatic Severe Carotid Stenosis Dr. Quan, Dr. Mirhashemi, Dr. Chiang N Engl J Med 2006; 355:
Prevention of Venous Thromboembolism 8 th ACCP Guidelines Chest 2008.
به نام خدا. دكتر محمد امامي فوق تخصص ريه عضو هيات علمي دانشگاه.
The Role of Thromboprophylaxis in Elective Spinal Surgery The Role of Thromboprophylaxis in Elective Spinal Surgery VA Elwell, N Koo Ng, D Horner & D Peterson.
Antiplatelet Therapy Use and the Risk of Venous Thromboembolic Events in the Double-Blind Raloxifene Use for the Heart (RUTH) Trial C. Duvernoy 1, A. Yeo.
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.
Warfarin Efficacy in Cancer Patients on Long-term Anticoagulation Neha Doshi, PharmD Candidate LeAnn B. Norris, PharmD, BCPS P. Brandon Bookstaver, PharmD,
Venous Thromboembolism Prophylaxis for Medical Inpatients Heather Hofmann, rev. 4/18/14 DSR2 Mini Lecture.
Risk assessment for VTE Dr Roopen Arya King’s College Hospital.
Risk Assessment for VTE. Which of the following best describes you?
Long-Term Outcomes in Patients Undergoing Coronary Stenting on Dual Oral Antiplatelet Treatment Requiring Oral Anticoagulant Therapy R. Rossini, G. Musumeci,
Higher Incidence of Venous Thromboembolism (VTE) in the Outpatient versus Inpatient Setting Among Patients with Cancer in the United States Khorana A et.
Perioperative Medicine Beyond Cardiac Clearance Pamela Pride MD July 31, 2012 MUSC.
 Deep Vein Thrombosis Josh Vrona, Hunter Dolan, Erin McCann.
Preoperative Hemoglobin A1c and the Occurrence of Atrial Fibrillation Following On-pump Coronary Artery Bypass surgery in Type-2 Diabetic Patients Akbar.
Therapeutic Delay and Survival after Surgery for Cancer of the Pancreatic Head with or without Preoperative Biliary Drainage Eshuis, van der Gaag, Rauws.
Low risk: young, with minor illnesses, who are to undergo operations lasting 30 min or less. Moderate risk: over 40 or with a debilitating illness who.
Oral Rivaroxaban Compared with Subcutaneous Enoxaparin for Extended Thromboprophylaxis After Total Hip Arthroplasty: The RECORD1 Trial Eriksson BI, Borris.
Can the Epidural Catheter Be Removed with Warfarin? Department of Anesthesiology Rush University Medical Center Rush Medical College Chicago, IL Asokumar.
Antiplatelet Therapy Use after Discharge among Acute Myocardial Infarction Patients with In-hospital Bleeding Tracy Y. Wang, MD, MHS, Lan Xiao, PhD, Karen.
Antithrombotic Therapy in Peripheral Artery Disease Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.
Venous Thromboembolism (VTE) Prophylaxis at Cesarean Section Phillip N. Rauk, MD.
Antithrombotic Therapy for VTE: CHEST Guidelines 2016
Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and.
Peripheral Artery Disease in Orthopaedic Patients with Asymptomatic Popliteal Artery Calcification on Plain X-ray Adam Podet, MS; Julia Volaufova, phD,;
The Risks of Thromboembolism Vs. Recurrent Gastrointestinal Bleeding after Interruption of Systemic Anticoagulation in Hospitalized Inpatients With Gastrointestinal.
Course Lecturer: Imon Rahman
R3 정상완. Introduction  EGC : Tumor invasion is limited to the mucosa or submucosa, regardless of lymph node involvement.  Accumulated histopathological.
Conclusions Results Methods Background Venous thrombo-embolism in patients undergoing neo- adjuvant chemotherapy and surgery for oesophago-gastric cancer.
Laparoscopic supracervical hysterectomy and total laparoscopic hysterectomy: A comparison of peri- operative outcomes Dr Kate Maclaran, Mr Nilesh Agarwal,
1 MMM October 2008 AVAIL ME Project Audit of Venous Thromboembolism Management in Middle East Hospitals Elham Mir,MD MPH Medical Affairs Clinical Operation.
Original article Chronic Renal Failure A Neglected Comorbidity of COPD Raffaele Antonelli Incalzi, MD; Andrea Corsonello, MD; Claudio Pedone, MD; Salvatore.
Pulmonary Embolism in Patients with Unexplained Exacerbation of COPD: Prevalence and Risk Factors Isabelle Tillie-Leblond, MD, PhD; Charles-Hugo Marquette,
Risk of high-grade dysplasia or carcinoma in gastric biopsy-proven low-grade dysplasia: an analysis using the Vienna classification R1 김진숙 / Prof. 장재영.
Date of download: 6/27/2016 From: Systematic Review: Comparative Effectiveness of Medications to Reduce Risk for Primary Breast Cancer Ann Intern Med.
CHEST 2013; 144(3): R3 김유진 / Prof. 장나은. Introduction 2  Cardiovascular diseases  common, serious comorbid conditions in patients with COPD cardiac.
Should Elderly Patients Undergo Additional Surgery After Non-Curative Endoscopic Resection for Early Gastric Cancer? Long-Term Comparative Outcomes R3.
Long-term outcomes of combination of endoscopic submucosal dissection and laparoscopic lymph node dissection without gastrectomy for early gastric cancer.
Long-term outcomes of endoscopic submucosal dissection (ESD) for superficial esophageal squamous cell neoplasms Satoshi Ono, MD, Mitsuhiro Fujishiro, MD,
Ryonho Koh, MD,1 Kingo Hirasawa, MD,1 Sei Yahara, MD,1 Hiroyuki Oka, MD,1 Kazuya Sugimori, MD,1 Manabu Morimoto, MD,1 Kazushi Numata, MD,1 Atsushi Kokawa,
1 Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled.
The NEW ENGLAND JOURNAL of MEDICINE Idarucizumab for Dabigatran Reversal R3 김동연 / F. 김선혜.
Dep. Of Hemato-Oncology R1. Choi In-Ah D-dimer Testing to Determine the Duration of Anticoagulation Therapy Gualtiero Palareti,M.D., Benilde Cosmi, M.D.,
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Preoperative Anemia and Postoperative Mortality in Neonates Goobie SM, Faraoni D,
CYNTHIA W. KO, STACY RIFFLE, LEANN MICHAELS, CYNTHIA MORRIS,
Ahmed Mohamed Abd Elmajeed 99
UOG Journal Club: June 2017 Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation: comparison with NICE.
Case 66 year old male with PMH of HTN, DM, ESRD on renal replacement TIW, stroke in 2011 with right side residual weakness, atrial fibrillation, currently.
EVALUATION OF THROMBOTIC RISK IN PATIENTS WITH POSITIVE ANTIPHOSPHOLIPID ANTIBODIES WITHOUT CLINICAL CRITERIA OF THE DISEASE 153 R. Demetrio Pablo1, P.
From: Temporal Trends in Anesthesia-related Adverse Events in Cesarean Deliveries, New York State, 2003–2012 Anesthes. 2015;123(5): doi: /ALN
Antithrombotic Therapy in Peripheral Artery Disease
Edward C. Rosenow, M.D.  Mayo Clinic Proceedings 
Presentation transcript:

The incidence of deep vein thrombosis in Japanese patients undergoing endoscopic submucosal dissection Masafumi Kusunoki, MD, Kazumasa Miyake, MD, PhD,Tomotaka Shindo, MD, PhD, Nobue Ueki, MD, PhD, Tetsuro Kawagoe, MD, PhD,Katya Gudis, PhD,Seiji Futagami, MD, PhD,Taku Tsukui, MD, PhD, Ikuyo Takagi, MD, PhD,Junro Hosaka, MD, PhD, Choitsu Sakamoto, MD, PhD Gastrointest Endosc 2011;74: R1. 엄유진 Journal conference

Pulmonary thromboembolism (PTE) deep vein thrombosis (DVT) ->regarded as sequential conditions venous thromboembolism (VTE) known risk factors contributing to VTE Advanced age, malignant disease, inflammation, protracted bed rest, obesity, ischemic heart disease, and pregnancy BACKGROUND BACKGROUND

Endoscopic submucosal dissection (ESD) permits en bloc resection for larger lesions higher rate of histologically complete resection (80%) : same position for a prolonged period during and after the procedure technical difficulties and frequent complications such as bleeding or perforation ESD procedure may be associated with a risk for VTE BACKGROUND BACKGROUND

D-dimer : marker of endogenous fibrinolysis : detectable in patients with DVT : sensitive but nonspecific marker of DVT : disease-specific screening for DVT has received little attention. Aim to evaluate DVT incidence and investigate the disease-specific features of D-dimer levels in patients undergoing ESD as a potential accurate marker of DVT. BACKGROUND BACKGROUND

METHODS METHODS Study design and patient population cohort study June 2007 to February 2009 at Nippon Medical School Inclusion criteria aged at least 20 years with gastric neoplasms indicated for ESD expanded criteria for ESD :extremely low risk of lymph node metastasis magnified chromoendoscopy and pathology evaluation of biopsy specimens

METHODS METHODS Exclusion criteria age 〉 90 years the presence of congenital and secondary coagulopathy, thrombophilia, malignancy other than gastric Neoplasm recent surgical procedures (within the preceding 12 months) pregnancy use of estrogens Acute inflammatory disease body mass index (BMI) exceeding 30 preexisting coagulation disorders, as evidenced by DVT on ultrasonography of the lower limbs in the preoperative state

METHODS METHODS Preoperative factors age, sex, BMI (18.5 kg/m2 normal value range 25.0 kg/m2) comorbidities (chronic heart failure, chronic obstructive pulmonary disease, chronic renal disease, stroke) use of anti-thrombotic drugs (warfarin, aspirin, ticlopidine, ethyl icosapentate, clopidogrel, and dipyridamole) taken anti-thrombotic drugs, therapy with these drugs was stopped from 5, 10, 14, 5, and 7 days before the ESD procedure, respectively, until at least the day after ESD

METHODS METHODS Measurement of plasma D-dimer levels venous blood samples : before ESD, immediately after ESD, and the day after ESD Diagnosis of DVT by ultrasonography of the lower limbs preoperatively and the day after ESD (24 hours after ESD). The time point with the largest AUC was defined as the most associated with DVT

RESULTS RESULTS Patient characteristics 71 patients with gastric neoplasms Excluded age exceeding 90 years (n = 1) incomplete follow-up (n =5) detection of DVT on preoperative ultrasonography (n = 1) malignancy other than gastric neoplasms (n = 2) recent surgical procedures(n = 2) 60 patients were studied and underwent ultrasonography postoperatively mean age : 71.2 years (range years) Women : 26.7% mean BMI : 22.4 (range kg/m2) mean operative time : minutes (range minutes)

RESULTS RESULTS Incidence of DVT after ESD 71 patients with gastric neoplasms DVT was detected in 6 (10.0%; 95% CI, 2.3%-17.7%) the day after ESD asymptomatic 60 patients were studied and underwent ultrasonography postoperatively

RESULTS RESULTS Influence of ESD on plasma D-dimer levels in venous blood samples D-dimer levels in venous blood samples Before ESD0.988 ± g/mL immediately after ESD1.383 ± g/mL the day after ESD1.997 ± g/mL

RESULTS RESULTS Figure 1. Differences in perioperative D-dimer levels in patients undergoing ESD. Influence of ESD on plasma D-dimer levels in venous blood samples

RESULTS RESULTS Figure 2. Receiver operating characteristic curve of D-dimer levels before endoscopic submucosal dissection Association with D-dimer levels and DVT development

RESULTS RESULTS Figure 3. Receiver operating characteristic curve of D-dimer levels measured immediately after endoscopic submucosal dissection

RESULTS RESULTS Table 1. Baseline Characteristics of Renal-Transplant Recipients and Donors, According to Risk and Treatment Group.

RESULTS RESULTS Factors in association with DVT development identified through univariate analyses Figure 1. Differences in perioperative D-dimer levels in patients undergoing ESD

RESULTS RESULTS Figure 1. Differences in perioperative D-dimer levels in patients undergoing ESD

RESULTS RESULTS Factors in association with DVT development identified through univariate analyses Warfarin therapy : started for 6 patients with DVT 3 days after ESD disappearance of the thrombus : confirmed by ultrasonography 3 to 6 months after ESD in all patients.

CONCLUSIONS CONCLUSIONS patients undergoing ESD : moderate risk for thromboembolism defined by the American College of Chest Physicians guidelines D-dimer levels, especially on the day after ESD, : specific features associated with DVT development in patients undergoing ESD.

CONCLUSIONS CONCLUSIONS high incidence of DVT after ESD procedures Mechanical thromboprophylaxis should be considered in these patients, except for those with comorbidities (might be aggravated by thromboprophylaxis) further study is needed to determine appropriate thromboprophylaxis recommendations for patients undergoing ESD. Arterial circulatory deficits cellulitis or thrombophlebitis of the lower limbs congestive heart failure acute myocardial infarction